Neuroendocrine control of energy homeostasis: Update on new insights

Progress in Brain Research

Volumn 181, Issue C, 2010, Pages 17-33

  Kalra, Satya P ^a   Kalra, Pushpa S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Appetite; Energy expenditure; Fat accrual; Hypothalamus; Leptin

Indexed keywords

GHRELIN; LEPTIN; STEROID;

ADIPOCYTE; APPETITE; ARCUATE NUCLEUS; ARTICLE; BIOAVAILABILITY; BLOOD BRAIN BARRIER; CHEMICAL COMPOSITION; ENERGY; ENERGY CONSUMPTION; ENERGY EXPENDITURE; ENERGY HOMEOSTASIS; GENE THERAPY; GENE TRANSFER; HOMEOSTASIS; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; METABOLIC SYNDROME X; NEUROANATOMY; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WEIGHT CONTROL; ANIMAL; BODY WEIGHT; ENERGY METABOLISM; GENETICS; HISTOLOGY; METABOLISM; NEUROSECRETION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; APPETITE; BODY WEIGHT; ENERGY METABOLISM; GHRELIN; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; LEPTIN; METABOLIC SYNDROME X; NEUROSECRETORY SYSTEMS; OBESITY; SIGNAL TRANSDUCTION;

EID: 77955491310     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)81002-3     Document Type: Article

References (119)

1. Alon, T. & Friedman, J. M. (2006). Late-onset leanness in mice with targeted ablation of melanin concentrating hormone neurons. Journal of Neuroscience, 26, 389-397.
2. Asakawa, A., Inui, A., Kaga, T., Yuzuriha, H., Nagata, T., Ueno, N., et al. (2001). Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology, 120, 337-345.
3. Bagnasco, M., Dube, M. G., Kalra, P. S., & Kalra, S. P. (2002a). Evidence for the existence of distinct central appetite and energy expenditure pathways and stimulation of ghrelin as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology, 143, 4409-4421.
4. Bagnasco, M., Dube, M. G., Katz, A., Kalra, P. S., & Kalra, S. P. (2003). Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin. Obesity Research, 11, 1463-1470.
5. Bagnasco, M., Kalra, P. S., & Kalra, S. P. (2002b). Plasma leptin levels are pulsatile in adult rats: Effects of gonadectomy. Neuroendocrinology, 75, 257-263.
6. Balthasar, N., Dalgaard, L. T., Lee, C. E., Yu, J., Funahashi, H., Williams, T., et al. (2005). Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell, 123, 493-505.
7. Bamshad, M., Aoki, V. T., Adkison, M. G., Warren, W. S., & Bartness, T. J. (1998). Central nervous system origins of the sympathetic nervous system outflow to white adipose tissue. American Journal of Physiology, 275, R291-R299.
8. Bamshad, M., Song, C. K., & Bartness, T. J. (1999). CNS origins of the sympathetic nervous system outflow to brown adipose tissue. American Journal of Physiology, 276, R1569-R1578.
9. Bartness, T. J. & Bamshad, M. (1998). Innervation of mammalian white adipose tissue: Implications for the regulation of total body fat. American Journal of Physiology, 275, R1399-R1411.
10. Bartness, T. J., Kay Song, C., Shi, H., Bowers, R. R., & Foster, M. T. (2005). Brain-adipose tissue cross talk. Proceedings of the Nutrition Society, 64, 53-64.
11. Beretta, E., Dube, M. G., Kalra, P. S., & Kalra, S. P. (2002). Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: Effects on serum ghrelin and appetite-regulating genes. Pediatric Research, 52, 189-198.
12. Bernardis, L. L. & Bellinger, L. L. (1996). The lateral hypothalamic area revisited: Ingestive behavior. Neuroscience and Biobehavioral Reviews, 20, 189-287.
13. Bochukova, E. G., Huang, N., Keogh, J., Henning, E., Purmann, C., Blaszczyk, K., et al. (2009). Large, rare chromosomal deletions associated with severe early-onset obesity. Nature, 463, 666-670.
14. Boghossian, S., Dube, M. G., Torto, R., Kalra, P. S., & Kalra, S. P. (2006a). Hypothalamic clamp on insulin release by leptin-transgene expression. Peptides, 27, 3245-3254.
15. Boghossian, S., Lecklin, A., Dube, M. G., Kalra, P. S., & Kalra, S. P. (2006b). Increased leptin expression in the dorsal vagal complex suppresses adiposity without affecting energy intake and metabolic hormones. Obesity, 14, 1003-1009.
16. Boghossian, S., Lecklin, A. H., Torto, R., Kalra, P. S., & Kalra, S. P. (2005). Suppression of fat deposition for the life time of rodents with gene therapy. Peptides, 26, 1512-1519.
17. Boghossian, S., Ueno, N., Dube, M. G., Kalra, P., & Kalra, S. (2007). Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin. Neurobiology of Aging, 28, 1594-1604.
18. Bonavera, J. J., Dube, M. G., Kalra, P. S., & Kalra, S. P. (1994). Anorectic effects of estrogen May be mediated by decreased neuropeptide-Y release in the hypothalamic paraventricular nucleus. Endocrinology, 134, 2367-2370.
19. Bray, G. A. (1998). Historical framework for the development of ideas about obesity. In George A. Bray, Claude Bouchard, & W. P. T. James (Eds.), Handbook of obesity Vol. 1 (pp. 1-29). New York: Marcel Dekker Inc.
20. Buijs, R. M., Chun, S. J., Niijima, A., Romijn, H. J., & Nagai, K. (2001). Parasympathetic and sympathetic control of the pancreas: A role for the suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake. The Journal of Comparative Neurology, 431, 405-423.
21. Carter, B. J. & Burstein, H. (2004). Adeno-associated virus and AAV vectors for gene delivery. In N. Templeton-Smith (Ed.), Theruapeutics mechanisms and strategies (pp. 71-1011). New York: Marcel Dekker.
22. Chen, Y. & Heiman, M. L. (2000). Chronic leptin administration promotes lipid utilization until fat mass is greatly reduced and preserves lean mass of normal female rats. Regulatory Peptides, 92, 113-119.
23. Chen, X. M., Hosono, T., Yoda, T., Fukuda, Y., & Kanosue, K. (1998). Efferent projection from the preoptic area for the control of non-shivering thermogenesis in rats. Journal of Physiology (Paris), 512, 883-892.
24. Clark, J. T., Kalra, P. S., Crowley, W. R., & Kalra, S. P. (1984). Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology, 115, 427-429.
25. Coll, A. P., Farooqi, I. S., & O'Rahilly, S. (2007). The hormonal control of food intake. Cell, 129, 251-262.
26. Dhillon, H., Ge, Y., Minter, R. M., Prima, V., Moldawer, L. L., Muzyczka, N., et al. (2000). Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice. Relationship with body weight change. Regulatory Peptides, 92, 97-105.
27. Dhillon, H., Kalra, S. P., & Kalra, P. S. (2001a). Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Molecular Therapy, 4, 139-145.
28. Dhillon, H., Kalra, S. P., Prima, V., Zolotukhin, S., Scarpace, P. J., Moldawer, L. L., et al. (2001b). Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: A long-term study. Regulatory Peptides, 99, 69-77.
29. Dhillon, H., Zigman, J. M., Ye, C., Lee, C. E., McGovern, R. A., Tang, V., et al. (2006). Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron, 49, 191-203.
30. Dietrich, M. O. & Horvath, T. L. (2009). GABA keeps up an appetite for life. Cell, 137, 1177-1179.
31. Dube, M. G., Beretta, E., Dhillon, H., Ueno, N., Kalra, P. S., & Kalra, S. P. (2002). Central leptin gene therapy blocks high fat diet-induced weight gain, hyperleptinemia and hyperinsulinemia: Effects on serum ghrelin levels. Current Medical Literature -Diabetes, 51, 1729-1736.
32. Dube, M. G., Kalra, S. P., & Kalra, P. S. (2007). Low abundance of NPY in the hypothalamus can produce hyperphagia and obesity. Peptides, 28, 475-479.
33. Dube, M. G., Torto, R., & Kalra, S. P. (2008). Increased leptin expression selectively in the hypothalamus suppresses inflammatory markers CRP and IL-6 in leptin-deficient diabetic obese mice. Peptides, 29, 593-598.
34. Dube, M. G., Xu, B., Kalra, P. S., Sninsky, C. A., & Kalra, S. P. (1999). Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats. Brain Research, 816, 38-46.
35. Ebihara, K., Kusakabe, T., Hirata, M., Masuzaki, H., Miyanaga, F., Kobayashi, N., et al. (2007). Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. Journal of Clinical Endocrinology Metabolism, 92, 532-541.
36. Farooqi, I. S. & O'Rahilly, S. (2005). Monogenic obesity in humans. Annual Review of Medicine, 56, 443-458.
37. Fischer, J., Koch, L., Emmerling, C., Vierkotten, J., Peters, T., Bruning, J. C., et al. (2009). Inactivation of the fto gene protects from obesity. Nature, 458, 894-898.
38. Flegal, K. M., Graubard, B. I., Williamson, D. F., & Gail, M. H. (2005). Excess deaths associated with underweight, overweight, and obesity. JAMA, 293, 1861-1867.
39. Fredriksson, R., Hagglund, M., Olszewski, P. K., Stephansson, O., Jacobsson, J. A., Olszewska, A. M., et al. (2008). The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology, 149, 2062-2071.
40. Friedman, J. M. (2009). Obesity: Causes and control of excess body fat. Nature, 459, 340-342.
41. Friedman, J. M. & Halaas, J. L. (1998). Leptin and the regulation of body weight in mammals. Nature, 395, 763-770.
42. Goldstone, A. P. (2006). The hypothalamus, hormones, and hunger: Alterations in human obesity and illness. Progress in Brain Research, 153, 57-73.
43. Gray, J., Yeo, G. S., Cox, J. J., Morton, J., Adlam, A. L., Keogh, J. M., et al. (2006). Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Current Medical Literature -Diabetes, 55, 3366-3371.
44. Grundy, S. M. (2004). Obesity, metabolic syndrome, and cardiovascular disease. Journal of Clinical Endocrinology Metabolism, 89, 2595-2600.
45. Heymsfield, S. B., Greenberg, A. S., Fujioka, K., Dixon, R. M., Kushner, R., Hunt, T., et al. (1999). Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial. JAMA, 282, 1568-1575.
46. Hill, J. O., Wyatt, H. R., Reed, G. W., & Peters, J. C. (2003). Obesity and the environment: Where do we go from here? Science, 299, 853-855.
47. Horvath, T. L., Diano, S., & van den Pol, A. N. (1999). Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations. Journal of Neuroscience, 19, 1072-1087.
48. Iwaniec, U. T., Boghossian, S., Lapke, P. D., Turner, R. T., & Kalra, S. P. (2007). Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice. Peptides, 28, 1012-1019.
49. Kalra, S. P. (2001). Circumventing leptin resistance for weight control. Proceedings of the National Academy of Sciences of the United States of America, 98, 4279-4281.
50. Kalra, S. P. (2007). Global life-long health benefits of repression of hypothalamic NPY system by central leptin gene therapy. Current Topics Medicinal Chemistry, 7, 1675-1681.
51. Kalra, S. P. (2008a). Central leptin insufficiency syndrome: An interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions. Peptides, 29, 127-138.
52. Kalra, S. P. (2008b). Disruption in the leptin-NPY link underlies the pandemic of diabetes and metabolic syndrome: New therapeutic approaches. Nutrition, 24, 820-826.
53. Kalra, S. P. (2009a). Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation. Peptides, 30, 1957-1963.
54. Kalra, S. P. (2009b). Increased leptin supply to hypothalamus by gene therapy confers life-long benefits on energy homeostasis, disease cluster of metabolic syndrome-diabetes type 1 and 2, dyslipidemia and cardiovascular ailmentsand bone remodeling. In S. Shioda, I. Homma, & Kato, N. (Eds.), Transmitters and modulators in health and disease (pp. 19-30). Tokyo: Springer.
55. Kalra, S. P., Bagnasco, M., Otukonyong, E. E., Dube, M. G., & Kalra, P. S. (2003). Rhythmic, reciprocal ghrelin and leptin signaling: New insight in the development of obesity. Regulatory Peptides, 111, 1-11.
56. Kalra, S. P., Dube, M. G., & Iwaniec, U. T. (2009). Leptin increases osteoblast-specific osteocalcin release through a hypothalamic relay. Peptides, 30, 967-973.
57. Kalra, S. P., Dube, M. G., Pu, S., Xu, B., Horvath, T. L., & Kalra, P. S. (1999). Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocrine Reviews, 20, 68-100.
58. Kalra, S. P., Dube, M. G., Sahu, A., Phelps, C. P., & Kalra, P. S. (1991). Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proceedings of the National Academy of Sciences of the United States of America, 88, 10931-10935.
59. Kalra, P. S., Dube, M. G., Xu, B., Farmerie, W. G., & Kalra, S. P. (1998a). Neuropeptide Y (NPY) Y1 receptor mRNA is upregulated in association with transient hyperphagia and body weight gain: Evidence for a hypothalamic site for concurrent development of leptin resistance. Journal of Neuroendocrinology, 10, 43-49.
60. Kalra, P. S., Dube, M. G., Xu, B., & Kalra, S. P. (1997). Increased receptor sensitivity to neuropeptide Y in the hypothalamus May underlie transient hyperphagia and body weight gain. Regulatory Peptides, 72, 121-130.
61. Kalra, S. P. & Kalra, P. S. (1996). Nutritional infertility: The role of the interconnected hypothalamic neuropeptide Y-galanin-opioid network. Frontiers in Neuroendocrinology, 17, 371-401.
62. Kalra, S. P. & Kalra, P. S. (2001). Viral vectors as probes to decipher brain circuitry for weight control. Trends in Endocrinology and Metabolism, 12, 377-378.
63. Kalra, S. P. & Kalra, P. S. (2003). Neuropeptide Y: A physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine, 22, 49-55.
64. Kalra, S. P. & Kalra, P. S. (2004a). NPY -an endearing journey in search of a neurochemcial on/off switch for appetite, sex and reproduction. Peptides, 25, 465-471.
65. Kalra, S. P. & Kalra, P. S. (2004b). NPY and cohorts in regulating appetite, obesity and metabolic syndrome: Beneficial effects of gene therapy. Neuropeptides, 38, 201-211.
66. Kalra, S. P. & Kalra, P. S. (2005). Gene transfer technology: A preventive neurotherapy to curb obesity, ameliorate metabolic syndrome and extend life-expectancy. Trends in Pharmacological Sciences, 26, 488-495.
67. Kalra, S. P.& Kalra, P. S. (2006a). Neuropeptide Y:Aconductor of the appetite-regulating orchestra in the hypothalamus. In A. J. Kastin (Ed.), The handbook of biologically active peptides (pp. 889-894). Burlington, MA: Academic Press.
68. Kalra, S. P. & Kalra, P. S. (2006b). Subjugation of hypothalamic NPY and cohorts with central leptin gene therapy alleviates dyslipidemia, insulin resistance, and obesity for lifetime. In Z. Zukowska, & G. Feuerstein (Eds.), NPY family of peptides in neurobiology, cardiovascular and metabolic disorders: Genes, functions and therapeutics (pp. 157-169). Switzerland: Birhauser Verlag Publishing House.
69. Kalra, S. P. & Kalra, P. S. (2007). To subjugate NPY is to improve the quality of life and live longer. Peptides, 28, 413-418.
70. Kalra, S. P., Ueno, N., & Kalra, P. S. (2005). Stimulation of appetite by ghrelin is regulated by leptin restraint: Peripheral and central sites of action. The Journal of Nutrition, 135, 1331-1335.
71. Kalra, S. P., Xu, B., Dube, M. G., & Kalra, P. S. (1998b). Nutritional infertility, mismanagement in central neuropeptidergic and peripheral insulin -leptin signaling. In W. Hansel, G. Bray, & Ryan, D. H. (Eds.), Nutrition and reproduction (pp. 25-70). Baton Rouge, LA: State University Press.
72. Kastin, A. J. & Pan, W. (2006). Intranasal leptin: Blood-brain barrier bypass (BBBB) for obesity? Endocrinology, 147, 2086-2087.
73. Keen-Rhinehart, E., Kalra, S. P., & Kalra, P. S. (2005). AAV mediated leptin receptor installation improves energy balance and the reproductive status of obese female koletsky rats. Peptides, 26, 2567-2578.
74. King, B. M. (2006). The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. Physiology & Behavior, 87, 221-244.
75. Kojima, S., Asakawa, A., Amitani, H., Sakoguchi, T., Ueno, N., Inui, A., et al. (2009). Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice. Peptides, 30, 962-966.
76. Kreier, F., Kap, Y. S., Mettenleiter, T. C., van Heijningen, C., van der Vliet, J., Kalsbeek, A., et al. (2006). Tracing from fat tissue, liver, and pancreas: A neuroanatomical framework for the role of the brain in type 2 diabetes. Endocrinology, 147, 1140-1147.
77. Kublaoui, B. M., Holder, J. L. Jr., Gemelli, T., & Zinn, A. R. (2006). Sim1 haploinsufficiency impairs melanocortinmediated anorexia and activation of paraventricular nucleus neurons. Molecular Endocrinology, 20, 2483-2492.
78. Lecklin, A. H., Dube, M. G., Torto, R., Kalra, P. S., & Kalra, S. P. (2005). Perigestational suppression of weight gain with central leptin gene therapy results in lower weight F1 generation. Peptides, 26, 1176-1187.
79. Lenz, A. & Diamond, F. B. Jr. (2008). Obesity: The hormonal milieu. Current Opinion Endocrinology Diabetes Obesity, 15, 9-20.
80. Lindqvist, A., de la Cour, C. D., Stegmark, A., Hakanson, R., & Erlanson-Albertsson, C. (2005). Overeating of palatable food is associated with blunted leptin and ghrelin responses. Regulatory Peptides, 130, 123-132.
81. Luiten, P. G., ter Horst, G. J., & Steffens, A. B. (1987). The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism. Progress of Neurobiology, 28, 1-54.
82. Luquet, S., Perez, F. A., Hnasko, T. S., & Palmiter, R. D. (2005). NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science, 310, 683-685.
83. Malhotra, A., Vashistha, H., Yadav, V. S., Dube, M. G., Kalra, S. P., Abdellatif, M., et al. (2009). Inhibition of p66ShcA redox activity in cardiac muscle cells attenuates hyperglycemia-induced oxidative stress and apoptosis. American Journal of Physiology. Heart and Circulatory Physiology, 296, H380-H388.
84. Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., et al. (1997). Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature, 387, 903-908.
85. Neary, M. T. & Batterham, R. L. (2009). Peptide YY: Food for thought. Physiology & Behavior, 97, 616-619.
86. Otukonyong, E. E., Dube, M. G., Torto, R., Kalra, P. S., & Kalra, S. P. (2005a). Central leptin differentially modulates ultradian secretory patterns of insulin, leptin and ghrelin independent of effects on food intake and body weight. Peptides, 26, 2559-2566.
87. Otukonyong, E. E., Dube, M. G., Torto, R., Kalra, P. S., & Kalra, S. P. (2005b). High fat diet-induced ultradian leptin and insulin hypersecretion and ghrelin is absent in obesityresistant rats. Obesity Research, I13, 991-999.
88. Park, J. Y., Chong, A. Y., Cochran, E. K., Kleiner, D. E., Haller, M. J., Schatz, D. A., et al. (2008). Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: The effect of long-term leptin therapy. Journal of Clinical Endocrinology Metabolism, 93, 26-31.
89. Plum, L., Belgardt, B. F., & Bruning, J. C. (2006). Central insulin action in energy and glucose homeostasis. The Journal of Clinical Investigation, 116, 1761-1766.
90. Powley, T. L., Opsahl, C. J., Cox, J. E., & Weingarten, H. P. (1980). The role of the hypothalmus in energy homeostasis. In P. J. Morgane & J. Planksepp (Eds.), Handbook of the hypothalamus. Part A: Behavioral studies of the hypothalamus Vol. 3 (pp. 211-298). New York: Marcel Dekker, Inc.
91. Pu, S., Dube, M. G., Kalra, S. P., & Kalra, P. S. (2003). 33rd annual society for neuroscience meeting (pp. W-33, Abs #831.7). New Orleans, LA: Society for Neuroscience.
92. Pu, S., Jain, M. R., Horvath, T. L., Diano, S., Kalra, P. S., & Kalra, S. P. (1999). Interactions between neuropeptide Y and gamma-aminobutyric acid in stimulation of feeding: A morphological and pharmacological analysis. Endocrinology, 140, 933-940.
93. Ren, D., Zhou, Y., Morris, D., Li, M., Li, Z., & Rui, L. (2007). Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. The Journal of Clinical Investigation, 117, 397-406.
94. Richard, D., Guesdon, B., & Timofeeva, E. (2009). The brain endocannabinoid system in the regulation of energy balance. Best Practice and Research Clinical Endocrinology Metabolism, 23, 17-32.
95. Rios, M., Fan, G., Fekete, C., Kelly, J., Bates, B., Kuehn, R., et al. (2001). Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Molecular Endocrinology, 15, 1748-1757.
96. Sahu, A. (2002). Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones. Journal of Neuroendocrinology, 14, 796-804.
97. Schwartz, M. W., Figlewicz, D. P., Baskin, D. G., Woods, S. C., & Porte, D. Jr. (1992). Insulin in the brain: A hormonal regulator of energy balance. Endocrine Reviews, 13, 387-414.
98. Shimizu, H., Oh, I. S., Okada, S., & Mori, M. (2009). Nesfatin-1: An overview and future clinical application. Endocrine Journal, 56, 537-543.
99. Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999). Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature, 401, 73-76.
100. Stricker, E. M. (Ed.) (1990). Handbook of behavioral neurobiology. In Neurobiology of food and fluid intake Vol. 10 (pp. 1-553). New York: Plenum Press.
101. Sved, A. F., Cano, G., & Card, J. P. (2001). Neuroanatomical specificity of the circuits controlling sympathetic outflow to different targets. Clinical and Experimental Pharmacology and Physiology, 28, 115-119.
102. Taymans, J. M., Vandenberghe, L. H., Haute, C. V., Thiry, I., Deroose, C. M., Mortelmans, L., et al. (2007). Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Human Gene Therapy, 18, 195-206.
103. Tong, Q., Ye, C. P., Jones, J. E., Elmquist, J. K., & Lowell, B. B. (2008). Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nature Neuroscience, 11, 998-1000.
104. Torto, R., Boghossian, S., Dube, M. G., Kalra, P. S., & Kalra, S. P. (2006). Central leptin gene therapy blocks ovariectomy-induced adiposity. Obesity (Silver Spring), 14, 1312-1319.
105. Ueno, N., Dube, M. G., Inui, A., Kalra, P. S., & Kalra, S. P. (2004). Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology, 145, 4176-4184.
106. Uyama, N., Geerts, A., & Reynaert, H. (2004). Neural connections between the hypothalamus and the liver. The Anatomical Record Part A, Discoveries Molecular Cellular, and Evolutionary Biology, 280, 808-820.
107. Van Heek, M., Compton, D. S., France, C. F., Tedesco, R. P., Fawzi, A. B., Graziano, M. P., et al. (1997). Dietinduced obese mice develop peripheral, but not central, resistance to leptin. The Journal of Clinical Investigation, 99, 385-390.
108. Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., et al. (2009). Functional brown adipose tissue in healthy adults. The New England Journal of Medicine, 360, 1518-1525.
109. Wang, Z. W., Zhou, Y. T., Kakuma, T., Lee, Y., Higa, M., Kalra, S. P., et al. (1999). Comparing the hypothalamic and extrahypothalamic actions of endogenous hyperleptinemia. Proceedings of the National Academy of Sciences of the United States of America, 96, 10373-10378.
110. Wilson, J. M. (2009). Progress in the commercial-scale production of adeno-associated viral vectors. Human Gene Therapy, 20, 695.
111. Wright, J. F. (2009). Transient transfection methods for clinical adeno-associated viral vector production. Human Gene Therapy, 20, 698-706.
112. Wu, Q., Boyle, M. P., & Palmiter, R. D. (2009). Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell, 137, 1225-1234.
113. Wynne, K., Stanley, S., McGowan, B., & Bloom, S. (2005). Appetite control. Journal of Endocrinology, 184, 291-318.
114. Xu, B., Goulding, E. H., Zang, K., Cepoi, D., Cone, R. D., Jones, K. R., et al. (2003). Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nature Neuroscience, 6, 736-742.
115. Xu, B., Kalra, P. S., Farmerie, W. G., & Kalra, S. P. (1999). Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: Effects of food restriction. Endocrinology, 140, 2868-2875.
116. Yeo, G. S., Connie Hung, C. C., Rochford, J., Keogh, J., Gray, J., Sivaramakrishnan, S., et al. (2004). A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nature Neuroscience, 7, 1187-1189.
117. Yokosuka, M., Xu, B., Pu, S., Kalra, P. S., & Kalra, S. P. (1998). Neural substrates for leptin and neuropeptide Y (NPY) interaction: Hypothalamic sites associated with inhibition of NPY-induced food intake. Physiology & Behavior, 64, 331-338.
118. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425-432.
119. Ziylan, Y. Z., Baltaci, A. K., & Mogulkoc, R. (2009). Leptin transport in the central nervous system. Cell Biochemistry and Function, 27, 63-70.